The Beauty Health Company (SKIN) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
SKIN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SKIN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 65.3% | -6.9% | -3.2% |
| 2024 | 54.5% | -20.3% | -8.7% |
| 2023 | 39.0% | -32.9% | -25.2% |
| 2022 | 68.0% | -7.1% | 12.1% |
| 2021 | 68.6% | -15.4% | -145.6% |
Download Data
Export SKIN earnings history in CSV or JSON format
Free sign-in required to download data
The Beauty Health Company (SKIN) Earnings Overview
As of May 6, 2026, The Beauty Health Company (SKIN) reported trailing twelve-month net income of -$10M, reflecting +55.6% year-over-year growth. The company earned $-0.07 per diluted share over the past four quarters, with a net profit margin of -3.2%.
Looking at the long-term picture, SKIN's historical earnings data spans multiple years. The company achieved its highest annual net income of $44M in fiscal 2022.
The Beauty Health Company is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ELF ($104M net income, 8.5% margin), IPAR ($201M net income, 11.3% margin), COTY (-$536M net income, -6.2% margin), SKIN has room to improve margins relative to the peer group. Compare SKIN vs ELF →
SKIN Earnings vs Peers
Earnings metrics vs comparable public companies
SKIN Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | +67.4% | -$21M | $-0.16 | -3.2% | -6.9% |
| 2024 | -$29M | +70.9% | -$68M | $-0.36 | -8.7% | -20.3% |
| 2023 | -$100M | -326.4% | -$131M | $-0.76 | -25.2% | -32.9% |
| 2022 | $44M | +111.7% | -$26M | $-0.23 | 12.1% | -7.1% |
| 2021 | -$379M | -1198.2% | -$40M | $-3.67 | -145.6% | -15.4% |
| 2020 | -$29M | -1681.1% | -$17M | $-0.85 | -24.5% | -14.4% |
| 2019 | -$2M | - | $13M | $-0.05 | -1.0% | 8.1% |
See SKIN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SKIN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SKIN vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonSKIN — Frequently Asked Questions
Quick answers to the most common questions about buying SKIN stock.
Is SKIN growing earnings?
SKIN EPS is $-0.07, with earnings growth accelerating to +55.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-10M.
What are SKIN's profit margins?
The Beauty Health Company net margin is -3.2%, with operating margin at -6.9%. Below-average margins reflect competitive or cost pressures.
How consistent are SKIN's earnings?
SKIN earnings data spans 2019-2025. The accelerating earnings trend is +55.6% YoY. Historical data enables comparison across business cycles.